Regardless, because modulating fatty acid oxidation is an attractive therapeutic target for the treatment of obesity, further research into the mechanisms governing the divergent expression of Acox1 and Ctp1a in mice at the suckling-weaning transition are warranted. This evidence concerns the gene ACOX1 and obesity due to melanocortin 4 receptor deficiency.